Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1040 | Pituitary - Clinical | ECE2017

Radiological study of clinically non-functioning pituitary macroadenomas: a single institutional experience

Moreno Cristina , Paja Miguel , Lizarraga Aitzol , Etxeberria Eider , Arrizabalaga Cristina , Ugarte Estibaliz , Izuzquiza Ana , Goni Fernando , Iglesias Natalia , Calles Laura

Introduction: When facing with non-functioning pituitary macroadenomas (NFPMA), radiological invasion is determinant to surgical approach, apart from histological biomarkers of pituitary tumor aggressiveness (Ki-67; p53 and mitotic index). Invasive tumors usually need additional surgery and/or radiotherapy. There are no much studies describing epidemiological data on aggressive pituitary tumors in clinical practice. We provide information regarding the radiological findings of...

ea0041ep814 | Obesity | ECE2016

Extra virgin olive oil and red wine polyphenols modulate fecal microbiota and reduce metabolic risk factors in high insulin resistant obese patients

Moreno-Indias Isabel , Sanchez-Alcoholado Lidia , Fernandez-Garcia Jose Carlos , Castellano-Castillo Daniel , Cardona-Diaz Fernando , Queipo-Ortuno Maria Isabel

Objectives: This study evaluated the prebiotic effect of a moderate intake of extra virgin olive oil (Evoo) and red wine (Rw) polyphenols on modulating the gut microbiota composition and the improvement of metabolic risk factors in obese subjects with high insulin resistance (HIR).Methodology: 10 obese patients with HIR (HOMA-IR>5.5) and 10 lean subject with low insulin resistance (HOMA-IR< 3.3) were included in a randomized and controlled interv...

ea0041ep868 | Pituitary - Basic | ECE2016

Serum proteases do not cleave prolactin to vasoinhibins at physiological pH

Triebel Jakob , Schauer Nicole , Hesslinger Felix , Moreno-Vega Aura Ileana , de la Escalera Gonzalo Martinez , Clapp Carmen , Bertsch Thomas

Background: The prolactin/vasoinhibin axis constitutes a novel endocrine axis in which the generation, secretion, and actions of the pituitary hormones prolactin and vasoinhibins are under control of the hypothalamus, the pituitary gland, and of regulators in the target tissue microenvironment. Vasoinhibins are generated in the pituitary gland and in multiple target tissues through proteolytic cleavage of prolactin; it is not known wether they are also produced in the circulat...

ea0059cc2 | Featured Clinical Cases | SFEBES2018

Missplicing due to a silent exonic substitution in the T-box transcription factor TBX19 resulting in Isolated ACTH deficiency

Maudhoo Ashwini , Maharaj Avinaash , Buonocore Federica , Martos-Moreno Gabriel Angel , Argente Jesus , Achermann John , Chan Li , Metherell Lou

Background: Congenital isolated ACTH deficiency (IAD) is a rare condition characterised by low plasma ACTH and serum cortisol with normal production of other pituitary hormones. TBX19 is a T-box pituitary restricted transcription factor important for POMC gene transcription and terminal differentiation of POMC-expressing cells. TBX19 gene mutations have been shown to cause neonatal-onset congenital IAD. To date 25 mutations in TBX19 have been described, five ...

ea0037ep388 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Contribution of glucose variability to HbA1c levels in patients with type 1 diabetes

Cardoso Luis , Batista Carla , Rodrigues Dircea , Moreno Carolina , Guelho Daniela , Vicente Nuno , Balsa Margarida , Martins Diana , Oliveira Diana , Carrilho Francisco

Background: Optimal management of type 1 diabetes requires full understanding of the relationships between the triad: HbA1c, fasting plasma glucose, and glucose variability (GV). As GV may contribute to HbA1c we assessed the influence of GV in HbA1c levels.Research design and methods: We retrospectively analysed 9393 h of continuous glucose monitorings (CGMs) from 61 patients with type 1 diabetes. Periods of 24 h with missing values were excluded. We cal...

ea0037ep819 | Pituitary: clinical | ECE2015

Endocrine manifestations of Langerhans cell histiocytosis

Cardoso Luis , Gomes Leonor , Rodrigues Dircea , Moreno Carolina , Guelho Daniela , Vicente Nuno , Balsa Margarida , Martins Diana , Oliveira Diana , Carrilho Francisco

Introduction: Langerhans cell histiocytosis (LCH) is a rare disorder characterized by proliferation/accumulation of cells phenotypically similar to skin Langerhans cells. Clinical presentation and aggressiveness are very heterogeneous, from benign to disseminated forms that cause significant morbi-mortality, particularly endocrine failures.Case 1: A 15-year-old Caucasian woman presented with a 14-month history of headaches, secondary amenorrhea. She repo...

ea0037ep1303 | Clinical Cases–Thyroid/Other | ECE2015

Medullary thyroid carcinoma in multiple endocrine neoplasia 2A: a therapeutic challenge

Cardoso Luis , Rodrigues Dircea , Costa Gracinda , Moreno Carolina , Guelho Daniela , Vicente Nuno , Balsa Margarida , Martins Diana , Oliveira Diana , Carrilho Francisco

Introduction: Medullary thyroid carcinoma (MTC) occurs in a hereditary pattern in 25% of cases. Virtually all patients with multiple endocrine neoplasia 2A (MEN2A) develop MTC. MTC aggressiveness and natural history varies according to the RET mutation. Prophylactic thyroidectomy may cure and/or prevent metastatic disease in most cases.Case report: A 27-year-old man with past history of colostomy at 5 months of age for Hirschsprung disease and t...

ea0035p296 | Clinical case reports Thyroid/Others | ECE2014

Type 2 polyglandular autoimmune syndrome and Turner syndrome

Moreno Carolina , Rodrigues Dircea , Vieira Alexandra , Ruas Luisa , Saraiva Joana , Guelho Daniela , Cardoso Luis , Vicente Nuno , Carrilho Francisco

Introduction: Individuals with Turner syndrome (TS) are prone to develop autoimmune conditions. The most frequently found are Hashimoto’s thyroiditis, type 1 diabetes, coeliac disease, and inflammatory bowel disease. In patients with TS, Addison’s disease isolated or combined with other autoimmune disease as type 2 polyglandular autoimmune syndrome, is a rare finding.Case report: We report a case of a 41-year-old female patient, with severe ast...

ea0035p325 | Clinical case reports Thyroid/Others | ECE2014

Hypoglycemia in type 1 diabetes mellitus patient – factual ou factitious?

Guelho Daniela , Paiva Isabel , Rodrigues Dircea , Baptista Carla , Saraiva Joana , Moreno Carolina , Dantas Rosa , Vicente Nuno , Cardoso Luis , Carrilho Francisco

Introduction: Factitious hypoglycemia results from surreptitious administration of insulin or insulin secretagogues. It can involve non-diabetic individuals with knowledge of hypoglycemiant drugs, or diabetics manipulating the doses.Clinical case: A 42-year-old women, type 1 diabetic since the age of 14, on intensive insulin therapy (A1C: 8.5%), was hospitalized for study of recurrent severe hypoglycemia in the last 2 months, despite successive insulin d...

ea0035p1008 | Thyroid (non-cancer) | ECE2014

Recurrence of Graves' disease after radioiodine treatment: factors related to treatment failure

Moreno Carolina , Pires Luis , Cardoso Luis , Ruas Luisa , Saraiva Joana , Guelho Daniela , Vicente Nuno , Costa Gracinda , Carrilho Francisco

Introduction: Radioiodine (RAI) therapy is an inexpensive and reliable therapeutic option for Graves’ disease (GD). However, individual characteristics of the disease can influence therapeutic success. The identification of these factors may help to predict outcome and select optimal pre-treatment conditions.Aim: To assess clinical, laboratory and radioactive parameters that may lead to RAI treatment failure in patients with GD....